CCMIC
ABBV icon

Cardinal Capital Management Inc (Canada)’s AbbVie ABBV Stock Holding History

Cardinal Capital Management Inc (Canada)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.9M Buy
273,719
+21,206
+8% +$4.56M 1.67% 21
2026
Q1 		$54.9M Buy
252,513
+60,677
+32% +$13.5M 1.48% 21
2025
Q4 		$60.1M Sell
191,836
-232
-0.1% -$52.9K 1.35% 20
2025
Q3 		$44.5M Buy
192,068
+1,295
+0.7% +$264K 1.28% 23
2025
Q2 		$35.4M Sell
190,773
-6,840
-3% -$1.27M 1.11% 27
2025
Q1 		$41.4M Buy
197,613
+289
+0.1% +$56.2K 1.41% 22
2024
Q4 		$35.1M Sell
197,324
-103
-0.1% -$18.9K 1.19% 26
2024
Q3 		$39M Buy
197,427
+588
+0.3% +$110K 1.61% 15
2024
Q2 		$33.8M Buy
196,839
+348
+0.2% +$57.6K 1.3% 19
2024
Q1 		$35.8M Sell
196,491
-3,561
-2% -$614K 1.59% 18
2023
Q4 		$31M Buy
200,052
+525
+0.3% +$76.5K 1.47% 19
2023
Q3 		$29.7M Buy
199,527
+1,447
+0.7% +$212K 1.55% 19
2023
Q2 		$26.7M Buy
198,080
+420
+0.2% +$61.6K 1.34% 25
2023
Q1 		$31.5M Buy
197,660
+24,546
+14% +$3.75M 1.71% 16
2022
Q4 		$28M Buy
173,114
+5,282
+3% +$810K 1.58% 18
2022
Q3 		$22.5M Buy
167,832
+3,960
+2% +$568K 1.37% 17
2022
Q2 		$25.1M Buy
163,872
+11,777
+8% +$1.8M 1.39% 16
2022
Q1 		$24.7M Buy
152,095
+137,885
+970% +$20M 1.2% 22
2021
Q4 		$1.92M Buy
14,210
+150
+1% +$17.7K 0.09% 45
2021
Q3 		$1.52M Buy
14,060
+2,233
+19% +$255K 0.08% 43
2021
Q2 		$1.33M Buy
11,827
+202
+2% +$22.8K 0.07% 44
2021
Q1 		$1.26M Buy
11,625
+1,425
+14% +$152K 0.07% 44
2020
Q4 		$1.09M Buy
10,200
+445
+5% +$42.8K 0.07% 47
2020
Q3 		$854K Buy
9,755
+465
+5% +$43.8K 0.06% 48
2020
Q2 		$912K Buy
9,290
+2,105
+29% +$185K 0.08% 43
2020
Q1 		$547K Buy
7,185
+6,530
+997% +$556K 0.05% 48
2019
Q4 		$58K Buy
+655
New +$54.4K ﹤0.01% 55

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cardinal Capital Management Inc (Canada)'s ABBV Position: Q2 2026 in Review

Cardinal Capital Management Inc (Canada) increased its AbbVie (ABBV) stake by 8.4% in Q2 2026, buying an estimated $4.56M and bringing the position to 273,719 shares worth $68.9M. The position accounts for 1.67% of the portfolio, ranked #21.

Cardinal Capital Management Inc (Canada) first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cardinal Capital Management Inc (Canada) held 273,719 shares of AbbVie worth $68.9M as of Q2 2026.
  • Cardinal Capital Management Inc (Canada) bought 21,206 AbbVie shares in Q2 2026, an estimated $4.56M.
  • AbbVie made up 1.67% of Cardinal Capital Management Inc (Canada)'s portfolio in Q2 2026, its #21 holding.
  • Cardinal Capital Management Inc (Canada) first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cardinal Capital Management Inc (Canada)'s 13F filing for Q2 2026, filed 10 Jul 2026.